Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04746014 · ClinicalTrials.gov registry record
Clearblue Pregnancy Test Lay User Usage Study
A clinical trial, sponsored by SPD Development Company Limited.
- Completed
- Registry status
- 306
- Enrollment target
NCT04746014 is a clinical trial that has completed, run by SPD Development Company Limited. The registered enrollment target is 306 participants.
The verdict
NCT04746014 has completed, sponsored by SPD Development Company Limited.
- COMPLETED
- Registry status
- 306 participants
- Enrollment target
Study Summary
The Clearblue home pregnancy test (HPT) is an over the counter urine hCG (human chorionic gonadotrophin) visual pregnancy test which is intended for the detection of pregnancy. This study will assess the performance of the HPT in the hands of the lay user by comparing their results when used according to the instructions for use (IFU) to (i) confirmed pregnancy status of the volunteers and (ii) to the results of trained study staff testing the same urine samples.
Interventions
- DIAGNOSTIC_TEST Clearblue Pregnancy Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2021-02-09 |
| Est. Completion | 2021-08-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04746014
The ClinicalTrials.gov registry entry for NCT04746014 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 306 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SPD Development Company Limited, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clearblue Pregnancy Test is the first listed.
NCT04746014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04746014 about?
NCT04746014 is a clinical study titled "Clearblue Pregnancy Test Lay User Usage Study". The Clearblue home pregnancy test (HPT) is an over the counter urine hCG (human chorionic gonadotrophin) visual pregnancy test which is intended for the detection of pregnancy. This study will assess the performance of the HPT in the hands of the lay user by comparing their results when used accordi...
What is the current status of trial NCT04746014?
This trial is currently completed. The enrollment target is 306 participants. The study started on 2021-02-09. Estimated completion is 2021-08-03.
What interventions are being tested in trial NCT04746014?
The interventions under investigation include: Clearblue Pregnancy Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04746014?
This trial is sponsored by SPD Development Company Limited, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.